© Copyright Acquisition International 2024 - All Rights Reserved.

Article Image - Biocon to go Ahead with Syngene IPO, Listing Likely in July
Posted 19th May 2015

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biotechnology major Biocon on Wednesday filed a prospectus with market regulator Securities and Exchange Board of India (Sebi) for the Initial Public Offer (IPO) of its research arm, Syngene, through which it aims to raise around Rs 600 crore for funding research and development (R&D).

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Biocon to go Ahead with Syngene IPO, Listing Likely in July

Biocon to go Ahead with Syngene IPO, Listing Likely in July

View Biography
Amarchand & Mangaldas

Biopharmaceuticals major Biocon on Tuesday said that the unlocking of the value from its contract research subsidiary Syngene would help the company fund its research and development programmes.

Syngene has already filed the draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI), seeking approval for an initial public offering (IPO). The company is estimated to be raising around Rs 600 crore through this public issue.

“We are unlocking value from Syngene to fund our R&D programmes, which include a rich pipeline of biosimilars and novel biologics. This fund infusion will help accelerate these programmes which are at various stages of development currently,” said Kiran Mazumdar-Shaw, chairperson and managing director, Biocon.

This is an offer for sale (OFS) by Biocon of a part of its shareholding in Syngene. Biocon along with its subsidiary Biocon Research Limited (BRL), currently holds an 84.5 per cent equity stake in Syngene. The company is offering to sell up to 22 million equity shares of face value of Rs 10 each, through Syngene’s IPO.

The offer includes a reservation of two million equity shares for Biocon’s public equity shareholders, being individuals and Hindu Undivided Families (HUFs). The offer would constitute 11 per cent of the post offer paid-up equity share capital of the company.

Established in 1993, Syngene offers a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition companies. The company’s service offerings also support the development of biosimilar and generic molecules.

During the nine months period-ended December 31, 2014, Syngene serviced 195 clients, ranging from multinational corporations to start-ups, including seven of the top 10 global pharmaceutical companies by sales for 2014.

Syngene had reported revenues of Rs 707.7 crore for the previous financial year-ended March 31, 2014 and Rs 617.5 crore for the nine months period ended December 31, 2014. Earlier this month, the company appointed Peter Bains as its Chief Executive Officer. Bains has been a part of Syngene since January 2010 as a director and has more than two decades of experience in the pharmaceutical space.

“Syngene has a proven track record of providing quality NME discovery, development and manufacturing services. It has long-standing partnerships with three of the world’s leading global healthcare organisations, including Bristol-Myers Squibb Co. and has attracted equity participation from India Value Fund recently, which is reflective of the scale, the value and the quality of the differentiated business model of Syngene,” added Mazumdar-Shaw.

Categories: Finance


You Might Also Like
Read Full PostRead - Eye Icon
Browne Jacobson advises LDC on £25m Aspin Group investment
Finance
14/05/2015Browne Jacobson advises LDC on £25m Aspin Group investment

Browne Jacobson advises LDC on £25m Aspin Group investment.

Read Full PostRead - Eye Icon
Who Are the Best Credit Rating Agencies?
News
16/08/2024Who Are the Best Credit Rating Agencies?

Credit rating agencies (CRAs) play a critical role in financial markets by providing a standardized assessment of an entity’s creditworthiness. These appraisals estimate the level of risk involved with investing in debt instruments, including bonds, pref

Read Full PostRead - Eye Icon
Kenya: Ensuring Economic Growth
Finance
12/10/2015Kenya: Ensuring Economic Growth

Mohammed Muigai is a leading law firm based in Kenya’s capital, Nairobi. Comprising six partners and five associates, allied to the finest legal and administrative support staff, the firm’s reputation as a market leader derives from a tradition of excellen

Read Full PostRead - Eye Icon
Four Must-Have Marketing Tools To Improve Your Business Success
News
20/04/2023Four Must-Have Marketing Tools To Improve Your Business Success

Marketing is undoubtedly one of the most crucial parts of running a successful business. In today\'s digital age, many marketing tools are available to companies of all sizes. But as you may already know, there are so many options; thus, it can be challenging

Read Full PostRead - Eye Icon
Distinguished in Dispute Resolution 2016 – Australia
Legal
31/07/2016Distinguished in Dispute Resolution 2016 – Australia

I am a barrister, mediator and arbitrator. As a barrister, I appear in courts and tribunals in Australia and elsewhere. I am qualified to appear in Australia, England and Wales and New York.

Read Full PostRead - Eye Icon
How a Full HSE policy for a Growing Business Positively Impacts Employee Performance
News
21/09/2023How a Full HSE policy for a Growing Business Positively Impacts Employee Performance

If you’re growing a business, you likely have a long “to-do” list. Let’s look at why having a full Health, Safety and Environment (HSE) policy should be right at the top. Why do you need an HSE policy in place as your business grows, an

Read Full PostRead - Eye Icon
Expert Witness
Innovation
06/09/2017Expert Witness

Expert Witness

Read Full PostRead - Eye Icon
The Future of Work Dichotomy in a Digital World
Innovation
01/02/2023The Future of Work Dichotomy in a Digital World

Any business leader hoping to return to ‘traditional’ ways of working is on a fast-track to failure. That horse has bolted. Not only have employees re-evaluated the concept of work, but they have the experience that proves digital technologies enable a fun

Read Full PostRead - Eye Icon
‘Advice Gap’ Revealed as More Than Half of British Adults Fail to Seek Financial Help
Finance
26/03/2015‘Advice Gap’ Revealed as More Than Half of British Adults Fail to Seek Financial Help

A majority of British adults are falling through an 'advice gap' by not making use of financial advisers, according to new research from unbiased.co.uk and MetLife.



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow